ClinicalTrials.Veeva

Menu

Inflammation and Steatosis: the Role of Alpha-defensin

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Fatty Liver
Inflammation

Treatments

Diagnostic Test: Immunohistochemical staining

Study type

Observational

Funder types

Other

Identifiers

NCT03358420
HYMC-103-16

Details and patient eligibility

About

The aim of this study is to examine the correlation between the severity of non-alcoholic steatohepatitis/non alcoholic fatty liver disease (NASH/NAFLD) in naïve and hepatitis C (HCV) positive patients and the amplitude of alpha-defensin immunohistochemical staining in liver biopsy.

Enrollment

50 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Fatty liver disease patients with liver biopsy

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Rami Abu Fanne, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems